Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75709828 | 7570982 | 8 | F | 2009 | 20160822 | 20100902 | 20160823 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-15256449 | BRISTOL MYERS SQUIBB | 0.00 | YR | F | Y | 6.76000 | KG | 20160823 | CN | US | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75709828 | 7570982 | 1 | PS | REYATAZ | ATAZANAVIR SULFATE | 1 | Transplacental | UNK | U | 21567 | CAPSULE, HARD | ||||||||
| 75709828 | 7570982 | 2 | SS | SUSTIVA | EFAVIRENZ | 1 | Transplacental | UNK | U | 0 | FILM-COATED TABLET | ||||||||
| 75709828 | 7570982 | 3 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 75709828 | 7570982 | 4 | SS | NORVIR | RITONAVIR | 1 | Transplacental | UNK | U | 0 | |||||||||
| 75709828 | 7570982 | 5 | C | CEFUROXIME. | CEFUROXIME | 1 | Transplacental | UNK | U | 0 | |||||||||
| 75709828 | 7570982 | 6 | C | BETAMETHASONE. | BETAMETHASONE | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 75709828 | 7570982 | 1 | Product used for unknown indication |
| 75709828 | 7570982 | 2 | Product used for unknown indication |
| 75709828 | 7570982 | 3 | Product used for unknown indication |
| 75709828 | 7570982 | 4 | Product used for unknown indication |
| 75709828 | 7570982 | 5 | Product used for unknown indication |
| 75709828 | 7570982 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 75709828 | 7570982 | OT |
| 75709828 | 7570982 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 75709828 | 7570982 | Cerebral palsy | |
| 75709828 | 7570982 | Congenital hydrocephalus | |
| 75709828 | 7570982 | Foetal exposure during pregnancy | |
| 75709828 | 7570982 | Intestinal perforation | |
| 75709828 | 7570982 | Intraventricular haemorrhage | |
| 75709828 | 7570982 | Microcephaly | |
| 75709828 | 7570982 | Neonatal respiratory distress syndrome | |
| 75709828 | 7570982 | Patent ductus arteriosus | |
| 75709828 | 7570982 | Peritonitis | |
| 75709828 | 7570982 | Premature baby | |
| 75709828 | 7570982 | Retinopathy of prematurity | |
| 75709828 | 7570982 | Strabismus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 75709828 | 7570982 | 4 | 20090613 | 0 |